EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

This list contains a non-exhaustive inventory of hazardous substances for purposes of Regulation (EU) 2017/746, including Chap. 2 (Placing on the market and putting into service) and Annex I (General Safety and Performance Requirements). It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 02 Май 2024. Database contains 4917 unique substances/entries.

Filter the list

Показване на 501 - 550 от 4 917 резултати.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC
sodium methanolate; sodium methoxide	204-699-5	124-41-4	Self-heat. 1; Skin Corr. 1B		Details
sodium metabisulphite	231-673-0	7681-57-4	Acute Tox. 4; Eye Dam. 1		Details
sodium hypochlorite, solution... % Cl active	231-668-3	7681-52-9	Skin Corr. 1B; Eye Dam. 1		Details
sodium hydroxide; caustic soda	215-185-5	1310-73-2	Skin Corr. 1A		Details
sodium hydrogensulphite ... %; sodium bisulphite ... %	231-548-0	7631-90-5	Acute Tox. 4		Details
sodium hydrogensulphate	231-665-7	7681-38-1	Eye Dam. 1		Details
sodium hydride	231-587-3	7646-69-7	Water-react. 1		Details
sodium fluoroacetate	200-548-2	62-74-8	Acute Tox. 2; Acute Tox. 1		Details
sodium fluoride	231-667-8	7681-49-4	Acute Tox. 3; Eye Irrit. 2; Skin Irrit. 2		Details
sodium ethanolate; sodium ethoxide	205-487-5	141-52-6	Self-heat. 1; Skin Corr. 1B		Details
sodium dithionite; sodium hydrosulphite	231-890-0	7775-14-6	Self-heat. 1; Acute Tox. 4		Details
sodium dichromate	234-190-3	10588-01-9	Ox. Sol. 2; Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1	C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c)	Details
Sodium dichromate	616-541-6	7789-12-0		C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c)	Details
sodium cyanate	213-030-6	917-61-3	Acute Tox. 4		Details
sodium chromate	231-889-5	7775-11-3	Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Acute Tox. 4; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1	C Carcinogenic (article 57a) M Mutagen (article 57b) R Toxic for reproduction (article 57c)	Details
sodium chlorate	231-887-4	7775-09-9	Ox. Sol. 1; Acute Tox. 3		Details
sodium carbonate	207-838-8	497-19-8	Eye Irrit. 2		Details
sodium bifluoride; sodium hydrogen difluoride	215-608-3	1333-83-1	Acute Tox. 3; Skin Corr. 1B		Details
sodium benzoyloxybenzene-4-sulfonate LU20	405-450-5	66531-87-1	Skin Sens. 1		Details
sodium azide	247-852-1	26628-22-8	Acute Tox. 2		Details
sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3(4-methoxy-2-sulfophenylazo)4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine RED ULK 1324	416-280-6	156769-97-0	Skin Sens. 1		Details
sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex DIRECT BLUE CA 36133	412-730-0	150522-10-4	Skin Corr. 1B		Details
sodium 5-n-butylbenzotriazole COBRATEC 435	404-450-2	118685-34-0	Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1		Details
sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate; acifluorfen-sodium	263-560-7	62476-59-9	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1		Details
sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate OCTAMER	417-550-6	168151-92-6	Skin Sens. 1		Details
sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate	425-460-3	1379676-84-2	Skin Sens. 1		Details
sodium 4-chloro-1-hydroxybutane-1-sulfonate BISULPHITE ADDUCT; GR59658A	406-190-5	54322-20-2	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1		Details
sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate ORANGE JOG 365	416-370-5	156738-27-1	Skin Sens. 1		Details
sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate ACID YELLOW HT 2803; MONOAZO YELLOW HT 2803	407-800-2	136213-75-7	Skin Sens. 1		Details
sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate ACTIZONE; PG 85; PHENOLESTER C; PHENOLESTER C/S	400-030-8	94612-91-6	Acute Tox. 3; STOT RE 1; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Sens. 1		Details
sodium 3-nitrobenzenesulphonate	204-857-3	127-68-4	Eye Irrit. 2; Skin Sens. 1		Details
sodium 3-chloroacrylate	-	4312-97-4	Acute Tox. 4		Details
sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate ACETESSIG-KRESIDINSULFOSÄURES NATRIUMSALZ	411-680-7	133167-77-8	Skin Sens. 1		Details
sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate	418-410-7	139122-78-4	Eye Irrit. 2		Details
sodium 3-(2H-benzotriazol-2- yl)-5-sec-butyl-4-hydroxybenzenesulfonate BENZTRIAZOL UV ABSORBER BUK 4499; BUK 4499; UV ABSORBER BUK 4499	403-080-9	92484-48-5	Eye Dam. 1		Details
sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate YELLOW E-JD 3442	410-150-2	147703-65-9	Skin Sens. 1		Details
sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate H: SÄUREGELB 2829	401-870-8	115035-41-1	Eye Dam. 1		Details
sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate AF-390	407-720-8	155160-86-4	Skin Sens. 1		Details
sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate AF-365	405-510-0	121216-78-2	Skin Irrit. 2; Skin Sens. 1		Details
sodium 2-ethylhexanolate NA-2-ETHYLHEXANOLAT	406-150-7	38411-13-1	Flam. Sol. 1; Skin Corr. 1B		Details
sodium 2-biphenylate; 2-phenylphenol, sodium salt	205-055-6	132-27-4	Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1		Details
sodium 2-benzoyloxy-1-hydroxyethane-sulfonate BENZOYL BISULFITE	410-680-4	1379676-76-2	Skin Sens. 1		Details
sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate NSGBB; YELLOW BROWN E-GLN	412-320-1	31361-99-6	Eye Dam. 1		Details
sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate	430-890-1	81992-66-7	Skin Sens. 1		Details
sodium 2-(nonanoyloxy)benzenesulfonate	434-360-9	91125-43-8	Eye Dam. 1; Skin Sens. 1		Details
sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate FAT 40'436; FAT 40'436/A; REACTIVE ORANGE TZ 3538	410-770-3	146177-84-6	Skin Sens. 1		Details
sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate	224-580-1	4418-26-2	Acute Tox. 4		Details
sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt REACTIVE ORANGE TZ 3931	413-990-8	149850-31-7	Skin Sens. 1		Details
sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate	422-100-7	102061-82-5	Eye Dam. 1; Skin Sens. 1		Details
sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate	420-800-7	1379804-37-1	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1		Details

Показване на 501 - 550 от 4 917 резултати.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 02 Май 2024. Database contains 4917 unique substances/entries.

Footer Nav Items